244 related articles for article (PubMed ID: 11007949)
1. Integrin-linked kinase (ILK): a "hot" therapeutic target.
Yoganathan TN; Costello P; Chen X; Jabali M; Yan J; Leung D; Zhang Z; Yee A; Dedhar S; Sanghera J
Biochem Pharmacol; 2000 Oct; 60(8):1115-9. PubMed ID: 11007949
[TBL] [Abstract][Full Text] [Related]
2. Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase.
Delcommenne M; Tan C; Gray V; Rue L; Woodgett J; Dedhar S
Proc Natl Acad Sci U S A; 1998 Sep; 95(19):11211-6. PubMed ID: 9736715
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of integrin-linked kinase (ILK) suppresses activation of protein kinase B/Akt and induces cell cycle arrest and apoptosis of PTEN-mutant prostate cancer cells.
Persad S; Attwell S; Gray V; Delcommenne M; Troussard A; Sanghera J; Dedhar S
Proc Natl Acad Sci U S A; 2000 Mar; 97(7):3207-12. PubMed ID: 10716737
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of ILK in PTEN-mutant human glioblastomas inhibits PKB/Akt activation, induces apoptosis, and delays tumor growth.
Edwards LA; Thiessen B; Dragowska WH; Daynard T; Bally MB; Dedhar S
Oncogene; 2005 May; 24(22):3596-605. PubMed ID: 15782140
[TBL] [Abstract][Full Text] [Related]
5. Cell-extracellular matrix interactions stimulate the AP-1 transcription factor in an integrin-linked kinase- and glycogen synthase kinase 3-dependent manner.
Troussard AA; Tan C; Yoganathan TN; Dedhar S
Mol Cell Biol; 1999 Nov; 19(11):7420-7. PubMed ID: 10523630
[TBL] [Abstract][Full Text] [Related]
6. Cell adhesion and the integrin-linked kinase regulate the LEF-1 and beta-catenin signaling pathways.
Novak A; Hsu SC; Leung-Hagesteijn C; Radeva G; Papkoff J; Montesano R; Roskelley C; Grosschedl R; Dedhar S
Proc Natl Acad Sci U S A; 1998 Apr; 95(8):4374-9. PubMed ID: 9539744
[TBL] [Abstract][Full Text] [Related]
7. The integrin-linked kinase regulates the cyclin D1 gene through glycogen synthase kinase 3beta and cAMP-responsive element-binding protein-dependent pathways.
D'Amico M; Hulit J; Amanatullah DF; Zafonte BT; Albanese C; Bouzahzah B; Fu M; Augenlicht LH; Donehower LA; Takemaru K; Moon RT; Davis R; Lisanti MP; Shtutman M; Zhurinsky J; Ben-Ze'ev A; Troussard AA; Dedhar S; Pestell RG
J Biol Chem; 2000 Oct; 275(42):32649-57. PubMed ID: 10915780
[TBL] [Abstract][Full Text] [Related]
8. Integration of cell attachment, cytoskeletal localization, and signaling by integrin-linked kinase (ILK), CH-ILKBP, and the tumor suppressor PTEN.
Attwell S; Mills J; Troussard A; Wu C; Dedhar S
Mol Biol Cell; 2003 Dec; 14(12):4813-25. PubMed ID: 12960424
[TBL] [Abstract][Full Text] [Related]
9. Modulation of Wnt3a-mediated nuclear beta-catenin accumulation and activation by integrin-linked kinase in mammalian cells.
Oloumi A; Syam S; Dedhar S
Oncogene; 2006 Dec; 25(59):7747-57. PubMed ID: 16799642
[TBL] [Abstract][Full Text] [Related]
10. The role of integrin-linked kinase (ILK) in cancer progression.
Persad S; Dedhar S
Cancer Metastasis Rev; 2003 Dec; 22(4):375-84. PubMed ID: 12884912
[TBL] [Abstract][Full Text] [Related]
11. Conditional knock-out of integrin-linked kinase demonstrates an essential role in protein kinase B/Akt activation.
Troussard AA; Mawji NM; Ong C; Mui A; St -Arnaud R; Dedhar S
J Biol Chem; 2003 Jun; 278(25):22374-8. PubMed ID: 12686550
[TBL] [Abstract][Full Text] [Related]
12. Regulation of protein kinase B/Akt-serine 473 phosphorylation by integrin-linked kinase: critical roles for kinase activity and amino acids arginine 211 and serine 343.
Persad S; Attwell S; Gray V; Mawji N; Deng JT; Leung D; Yan J; Sanghera J; Walsh MP; Dedhar S
J Biol Chem; 2001 Jul; 276(29):27462-9. PubMed ID: 11313365
[TBL] [Abstract][Full Text] [Related]
13. Targeting integrin-linked kinase inhibits Akt signaling pathways and decreases tumor progression of human glioblastoma.
Koul D; Shen R; Bergh S; Lu Y; de Groot JF; Liu TJ; Mills GB; Yung WK
Mol Cancer Ther; 2005 Nov; 4(11):1681-8. PubMed ID: 16275989
[TBL] [Abstract][Full Text] [Related]
14. Integrin-linked kinase and PINCH: partners in regulation of cell-extracellular matrix interaction and signal transduction.
Wu C
J Cell Sci; 1999 Dec; 112 ( Pt 24)():4485-9. PubMed ID: 10574698
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of integrin linked kinase (ILK) suppresses beta-catenin-Lef/Tcf-dependent transcription and expression of the E-cadherin repressor, snail, in APC-/- human colon carcinoma cells.
Tan C; Costello P; Sanghera J; Dominguez D; Baulida J; de Herreros AG; Dedhar S
Oncogene; 2001 Jan; 20(1):133-40. PubMed ID: 11244511
[TBL] [Abstract][Full Text] [Related]
16. New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia.
Hales EC; Taub JW; Matherly LH
Cell Signal; 2014 Jan; 26(1):149-61. PubMed ID: 24140475
[TBL] [Abstract][Full Text] [Related]
17. Modulation of integrin signal transduction by ILKAP, a protein phosphatase 2C associating with the integrin-linked kinase, ILK1.
Leung-Hagesteijn C; Mahendra A; Naruszewicz I; Hannigan GE
EMBO J; 2001 May; 20(9):2160-70. PubMed ID: 11331582
[TBL] [Abstract][Full Text] [Related]
18. Mammary epithelial-specific expression of the integrin-linked kinase (ILK) results in the induction of mammary gland hyperplasias and tumors in transgenic mice.
White DE; Cardiff RD; Dedhar S; Muller WJ
Oncogene; 2001 Oct; 20(48):7064-72. PubMed ID: 11704830
[TBL] [Abstract][Full Text] [Related]
19. Inactivation of integrin-linked kinase induces aberrant tau phosphorylation via sustained activation of glycogen synthase kinase 3beta in N1E-115 neuroblastoma cells.
Ishii T; Furuoka H; Muroi Y; Nishimura M
J Biol Chem; 2003 Jul; 278(29):26970-5. PubMed ID: 12714590
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of hyperactive integrin-linked kinase leads to increased cellular radiosensitivity.
Cordes N
Cancer Res; 2004 Aug; 64(16):5683-92. PubMed ID: 15313908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
